Informing Canada’s Cancer Drug Funding Decisions With Scientific Evidence and Patient Perspectives: The Pan-Canadian Oncology Drug Review.

Informing Canada’s cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review.

Curr Oncol. 2013 Apr; 20(2): 121-4
Hoch JS, Sabharwal M

HubMed – drug